Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
This study has been completed.
Sponsor:
St. Franziskus Hospital
Information provided by:
St. Franziskus Hospital
ClinicalTrials.gov Identifier:
NCT01170481
First received: July 21, 2010
Last updated: July 19, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Assessment of optic disc morphology can be difficult in patients with uveitis and papilloedema. Therefore different optical coherence tomography (OCT) and laser scanning techniques may help to detect damage to the retinal nerve fibre layer.
Condition |
---|
Uveitis Glaucoma |
Study Type: | Observational |
Study Design: | Observational Model: Case Control Time Perspective: Prospective |
Official Title: | Retinal Nerve Fibre Layer in Uveitic Secondary Glaucoma |
Resource links provided by NLM:
Further study details as provided by St. Franziskus Hospital:
Primary Outcome Measures:
- Alterations of retinal nerve fibre layer by optical coherence tomography [ Time Frame: once at study entry ] [ Designated as safety issue: No ]Baseline comparision of retinal nerve fibre layer thickness in patients with uveitis and with or without papilloedema at study entry. No follow-up examination scheduled
Estimated Enrollment: | 50 |
Study Start Date: | July 2009 |
Study Completion Date: | April 2011 |
Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
papilloedema without glaucoma |
papilloedema with glaucoma |
glaucoma without papilloedema |
Eligibility
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Study Population
all patients with anterior or intermediate uveitis and papillooedema in fluoreszein angiography.
Criteria
Inclusion Criteria:
- anterior or intermediate uveitis
- papilloedema
- glaucoma
Exclusion Criteria:
- dense cataract
- dense vitreous opacification
- circular posterior synechiae
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01170481
Locations
Germany | |
Department of Ophthalmology at St.-Franziskus Hospital | |
Muenster, Germany, 48145 |
Sponsors and Collaborators
St. Franziskus Hospital
Investigators
Study Chair: | Arnd Heiligenhaus, MD | Department at St. Franziskus Hospital |
More Information
Additional Information:
No publications provided
Keywords provided by St. Franziskus Hospital:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 17, 2012
Additional Information:
Related Info 
No publications provided
Responsible Party: | Arnd Heiligenhaus M.D., Department of Ophthalmology at St.-Franziskus Hospital Muenster |
ClinicalTrials.gov Identifier: | NCT01170481 History of Changes |
Other Study ID Numbers: | 2008-128-f-S |
Study First Received: | July 21, 2010 |
Last Updated: | July 19, 2011 |
Health Authority: | Germany: Ethics Commission |
Keywords provided by St. Franziskus Hospital:
anterior and intermediate uveitis papilloedema |
Additional relevant MeSH terms:
Glaucoma Papilledema Uveitis Ocular Hypertension Eye Diseases |
Optic Nerve Diseases Cranial Nerve Diseases Nervous System Diseases Uveal Diseases |
ClinicalTrials.gov processed this record on October 17, 2012